A phase 3 trial of L-Glutamine in sickle cell disease

Research output: Contribution to journal › Letter › peer-review

21 Scopus citations

Original language	English
Pages (from-to)	1879
Number of pages	1
Journal	New England Journal of Medicine
Volume	379
Issue number	19
DOIs	https://doi.org/10.1056/NEJMc1811050
State	Published - Nov 8 2018

Access to Document

@article{dbc2d6c2b475413fa01847c9889fbff0,

title = "A phase 3 trial of L-Glutamine in sickle cell disease",

author = "\{Kumar Guddati\}, A. and \{Vamsi Kota\}, Kota",

year = "2018",

month = nov,

day = "8",

doi = "10.1056/NEJMc1811050",

language = "English",

volume = "379",

pages = "1879",

journal = "New England Journal of Medicine",

issn = "0028-4793",

number = "19",

}

TY - JOUR

T1 - A phase 3 trial of L-Glutamine in sickle cell disease

AU - Kumar Guddati, A.

AU - Vamsi Kota, Kota

PY - 2018/11/8

Y1 - 2018/11/8

UR - https://www.scopus.com/pages/publications/85056423729

U2 - 10.1056/NEJMc1811050

DO - 10.1056/NEJMc1811050

M3 - Letter

C2 - 30406979

AN - SCOPUS:85056423729

SN - 0028-4793

VL - 379

SP - 1879

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 19

ER -